A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin

Last updated: April 24, 2016
Sponsor: The Center for the Biology of Chronic Disease
Overall Status: Completed

Phase

N/A

Condition

Cytomegalovirus Infections

Herpes Simplex Infections

Chickenpox (Varicella Zoster Infection)

Treatment

N/A

Clinical Study ID

NCT02715752
022015
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This study measured the changes in health-related complaints by analyzing charts of individuals, who are infected with a latent virus, who have used Gene-Eden-VIR/Novirin.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Latent viral infection with either HSV, HPV, VZV, EBV, or CMV

  • Taking Gene-Eden-VIR/Novirin

Exclusion

Exclusion Criteria:

  • Use of other antiviral treatments

Study Design

Total Participants: 1000
Study Start date:
January 01, 2016
Estimated Completion Date:
March 31, 2016

Study Description

The medical community calls the movement from severe to mild disease and from mild to normal health, 'relieving symptoms', and the interventions that cause such movement, drugs, medications, or therapies. The alternative community calls the movement from normal health to superior health, 'boosting health' (or boosting the immune system, or improving your sex drive, or boosting any another well functioning physiological system), and the interventions that cause such movement, natural remedies, dietary supplements, complementary treatments, etc. In general, these interventions aim to achieve superior performance of a normal human body. Of course, boosting the body's normal performance improves many of its capabilities, such as higher resistance to diseases, faster recovery from fatigue, better mental concentration, etc. Each movement presents different objectives. Relieving symptoms represents the ability of an intervention to reduce the frequency, duration, and severity of a disease. In contrast, boosting health represents the ability of an intervention to increase the frequency, duration, and quality of a person's health. In the current study, the investigators would like to measure the changes in health-related complaints by analyzing charts of individuals, who are infected with latent virus, and who have used Gene-Eden-VIR/Novirin.

Connect with a study center

  • The Center for the Biology of Chronic Disease

    Valley Cottage, New York 10989
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.